Clinical Application Value of Deep Learning-Based "Opportunistic Screening" for Malignant Tumors on Routine Non-Contrast Chest-Abdomen-Pelvis CT

ConditionTumor
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorLian Yang

About this trial

This study aims to develop and validate a deep learning-based opportunistic multi-cancer screening system using routine non-contrast chest-abdomen-pelvis CT examinations, including CHANCE-Breast, CHANCE-Liver, CHANCE-Kidney, and CHANCE-Bladder, for the early detection of breast, liver, kidney, and bladder cancers. In addition, the study will assess a human-AI collaborative framework to determine its potential for improving cancer detection and reducing missed diagnoses in clinical practice.

Eligibility criteria

Qualifiers

Patients with a confirmed diagnosis of the target malignancy who received treatment at our institution;

Diagnostic-quality CT images without substantial metal or motion artifacts and with complete anatomical coverage of the target organ (breast, liver, kidney, or bladder);

Availability of complete pre-treatment non-contrast CT imaging data.

Disqualifiers

Non-diagnostic image quality;

Absence of a definitive reference-standard diagnosis;

Incomplete clinical or imaging data.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

100,000 Participants
are grouped into 3 trial groups

Locations

1
Union Hospital,Tongji Medical College,Huazhong University of Science and Technology430000, WuhanHubei, China

Sponsors and collaborators

Lian Yang

Lead sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Sponsor institution